The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

Cited by (1,000)

Items 101–200 of 1,000

1. Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance
   Linlin Shi, Jianyong Sheng, Guozhong Chen, Peng Zhu, Changping Shi, Bei Li, Chaiwoo Park, Jingyi Wang, Bixiang Zhang, Zhi Liu et al. · 2020 · Journal for ImmunoTherapy of Cancer
2. Intestinal bacteria and colorectal cancer: etiology and treatment
   Michael W. Dougherty, Christian Jobin · 2023 · Gut Microbes
3. Mechanisms of Resistance to Immune Checkpoint Blockade
   David Liu, Russell William Jenkins, Ryan Joseph Sullivan · 2018 · American Journal of Clinical Dermatology
4. Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
   Sunny Kumar, Mouli Chatterjee, Pratyasha Ghosh, Kirat Kumar Ganguly, Malini Basu, Mrinal K. Ghosh · 2022 · Genes & Diseases
5. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
   Laura Chambers, Emily Esakov Rhoades, Rashmi Bharti, Chad Braley, Surabhi Tewari, Lexie Trestan, Zahraa Alali, Defne Bayık, Justin Durla Lathia, Naseer Sangwan et al. · 2022 · Cancer Research
6. The current knowledge concerning solid cancer and therapy
   Masoud Najafi, Jamal Majidpoor, Heidar Toolee, Keywan Mortezaee · 2021 · Journal of Biochemical and Molecular Toxicology
7. Recent updates on cancer immunotherapy
   Ming Liu, Fukun Guo · 2018 · Precision Clinical Medicine
8. Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events—A Comprehensive Review
   Josefien W. Hommes, Rik Jasper Verheijden, Karijn P.M. Suijkerbuijk, Dörte Hamann · 2021 · Frontiers in Oncology
9. Breast and gut microbiome in health and cancer
   Jilei Zhang, Yinglin Xia, Jun Sun · 2020 · Genes & Diseases
10. The role of gut microbiota in intestinal disease: from an oxidative stress perspective
    Yiqi Sun, Xurui Wang, Lei Li, Chao Zhong, Yu Zhang, Xiangdong Yang, Mingyue Li, Chao Yang · 2024 · Frontiers in Microbiology
11. Mechanisms of resistance to immune checkpoint inhibitors
    Joji Nagasaki, Takamasa Ishino, Yosuke Togashi · 2022 · Cancer Science
12. Immunogenic cell death in colon cancer prevention and therapy
    Hang Ruan, Brian J. Leibowitz, Lin Zhang, Jian Yu · 2020 · Molecular Carcinogenesis
13. Recent developments in immunotherapy for gastrointestinal tract cancers
    Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, Wen‐Fei Li, Lin Cong, Jialin Lu, Liyang Mo, Huizhen Liu, Siyi He, Chao Yu et al. · 2024 · Journal of Hematology & Oncology
14. Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
    Chenyue Zhang, Chenxing Zhang, Haiyong Wang · 2023 · Cancer Letters
15. Prognostic correlations with the microbiome of breast cancer subtypes
    Sagarika Banerjee, Zhi Wei, Tian Tian, Dipayan Bose, Natalie N. C. Shih, Michael D. Feldman, Thaer Khoury, Angela De Michele, Erle S. Robertson · 2021 · Cell Death and Disease
16. Predictive biomarkers for response to immune checkpoint inhibition
    Benjamin Shum, James Larkin, Samra Turajlic · 2021 · Seminars in Cancer Biology
17. Probiotic Lactobacillus casei: Effective for Managing Childhood Diarrhea by Altering Gut Microbiota and Attenuating Fecal Inflammatory Markers
    Hung-Hsiang Lai, Cheng‐Hsun Chiu, Man‐Shan Kong, Chee‐Jen Chang, Chien‐Chang Chen · 2019 · Nutrients
18. Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
    Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, Marcello Tiseo, Marco Tucci, Vincenzo Adamo, Luigia Stefania Stucci, Alessandro Russo, Enrica T. Tanda, Francesco Spagnolo et al. · 2020 · European Journal of Cancer
19. The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies
    Jun Gong, Alex Chehrazi‐Raffle, Veronica Placencio-Hickok, Michelle Guan, Andrew Eugene Hendifar, Ravi Salgia · 2019 · Clinical and Translational Medicine
20. Antibacterial Fusobacterium nucleatum ‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer
    Linfu Chen, Rui Zhao, Jingjing Shen, Nanhui Liu, Zixuan Zheng, Miao Yu, Jiafei Zhu, Lin Zhang, Yingyao Wang, Huapan Fang et al. · 2023 · Advanced Materials
21. Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolites
    Guangqi Gao, Siyuan Shen, Tao Zhang, Jiachao Zhang, Shi Wei Huang, Zhihong Sun, Heping Zhang · 2023 · EBioMedicine
22. Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota
    Gao, Guangqi, Ma, Teng, Zhang, Tao, Jin, Hao, Li, Yalin, Kwok, Lai-Yu, Zhang, Heping, Sun, Zhihong · 2021 · Frontiers in Immunology
23. Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy
    Jiaao Sun, Feng Chen, Guangzhen Wu · 2023 · The ISME Journal
24. An intact gut microbiome protects genetically predisposed mice against leukemia
    Vicente-Dueñas, Carolina, Janssen, Stefan, Oldenburg, Marina, Auer, Franziska, González-Herrero, Inés, Casado-García, Ana, Isidro-Hernández, Marta, Raboso-Gallego, Javier, Westhoff, Philipp, Pandyra, Aleksandra A. et al. · 2020 · Blood
25. Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
    Tina Cascone, Annikka Weissferdt, Myrna C. B. Godoy, William N. William, Cheuk Hong Leung, Heather Yan Lin, Sreyashi Basu, Shalini Singh Yadav, Apar Pataer, Kyle Gregory Mitchell et al. · 2021 · Nature Communications
26. Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches
    Dongkui Song, Thomas B. Powles, Lei Shi, Lirong Zhang, Molly A. Ingersoll, Yong‐Jie Lu · 2019 · The Journal of Pathology
27. Impact of Different Exercise Modalities on the Human Gut Microbiome
    Dierdra K. Bycura, Anthony C. Santos, Arron Shiffer, Shari Kyman, Kyle N. Winfree, Jay T. Sutliffe, Talima Pearson, Derek L. Sonderegger, Emily K. Cope, J. Gregory Caporaso · 2021 · Sports
28. Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment
    Jennifer Borowsky, Koichiro Haruki, Mai Chan Lau, Andressa Dias Costa, Juha P. Väyrynen, Tomotaka Ugai, Kota Arima, Annacarolina da Silva, Kristen D. Felt, Melissa M. Zhao et al. · 2021 · Clinical Cancer Research
29. KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancer
    Alessandro Rizzo, Antonio Cusmai, Silvana Acquafredda, Francesco Giovannelli, Lucia Rinaldi, Andrea Misino, Gennaro Palmiotti · 2022 · Future Oncology
30. Association of gut microbiome and primary liver cancer: A two‐sample Mendelian randomization and case–control study
    Jun Ma, Jialiang Li, Jin Chen, Jinhuan Yang, Chongming Zheng, Kaiwen Chen, Yitong Xie, Yi Yang, Zhiyuan Bo, Jingxian Wang et al. · 2022 · Liver International
31. Diet, Microbiome, and Cancer Immunotherapy—A Comprehensive Review
    Michał Szczyrek, Paulina Bitkowska, Patryk Chunowski, Paulina Czuchryta, Paweł Adam Krawczyk, Janusz Milanowski · 2021 · Nutrients
32. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls
    Sims, Travis T., Colbert, Lauren E., Zheng, Jiali, Delgado Medrano, Andrea Y., Hoffman, Kristi L., Ramondetta, Lois, Jazaeri, Amir, Jhingran, Anuja, Schmeler, Kathleen M., Daniel, Carrie R. et al. · 2019 · Gynecologic Oncology
33. Lactobacillus casei CCFM1074 Alleviates Collagen-Induced Arthritis in Rats via Balancing Treg/Th17 and Modulating the Metabolites and Gut Microbiota
    Zhexin Fan, R. Paul Ross, Catherine Stanton, Bao Hou, Jianxin Zhao, Hao Zhang, Bo Kyung Yang, Wei Chen · 2021 · Frontiers in Immunology
34. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome‐driven neoplasms
    Tsuyoshi Hamada, Jonathan Andrew Nowak, Danny A. Milner, Mingyang Song, Shuji Ogino · 2019 · The Journal of Pathology
35. Microbial transformation of dietary xenobiotics shapes gut microbiome composition
    Elizabeth J. Culp, Nora T Nelson, Andrew A Verdegaal, Andrew L. Goodman · 2024 · Cell
36. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
    Cogdill, Alexandria P., Gaudreau, Pierre Olivier, Arora, Reetakshi, Gopalakrishnan, Vancheswaran, Wargo, Jennifer A. · 2018 · Trends in Immunology
37. Immunotherapy in Non–Small-Cell Lung Cancer Patients With Performance Status 2: Clinical Decision Making With Scant Evidence
    Antonio Passaro, Gianluca Spitaleri, Bishal Gyawali, Filippo de Marinis · 2019 · Journal of Clinical Oncology
38. Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection
    Geert D’Haens, Christian Jobin · 2019 · Gastroenterology
39. Intestinal microbiota: a new force in cancer immunotherapy
    Zhujiang Dai, Jingqiu Zhang, Qi Wu, Huiwen Fang, Chunfeng Shi, Zhen Li, Chaobiao Lin, Dong Tang, Daorong Wang · 2020 · Cell Communication and Signaling
40. Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
    Tianhang Li, Tianyao Liu, Wenjie Zhu, Shangxun Xie, Zihan Zhao, Baofu Feng, Hongqian Guo, Rong Yang · 2021 · Clinical Medicine Insights Oncology
41. Probiotics in microbiome ecological balance providing a therapeutic window against cancer
    Nirmala Sehrawat, Mukesh Kumar Yadav, Manoj Pratap Singh, Vikas Kumar, Varruchi Sharma, Anil Kumar Sharma · 2020 · Seminars in Cancer Biology
42. The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer
    Eiki Ichihara, Daijiro Harada, Koji Inoue, Ken Sato, Shinobu Hosokawa, Daizo Kishino, Kazuhiko Watanabe, Nobuaki Ochi, Naohiro Oda, Naofumi Hara et al. · 2019 · Lung Cancer
43. Propionate and Butyrate Produced by Gut Microbiota after Probiotic Supplementation Attenuate Lung Metastasis of Melanoma Cells in Mice
    Lili Chen, Xinyu Zhou, Yawei Wang, Dake Wang, Yueshuang Ke, Xianlu Zeng · 2021 · Molecular Nutrition & Food Research
44. A randomised trial of probiotics to reduce severity of physiological and microbial disorders induced by partial gastrectomy for patients with gastric cancer
    Cihua Zheng, Tingtao Chen, Yuqing Wang, Yuan Gao, Yao Kong, Zhaoxia Liu, Xiaorong Deng · 2019 · Journal of Cancer
45. Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology
    Virgile Raufaste-Cazavieille, Raoul Santiago, Arnaud Droit · 2022 · Frontiers in Molecular Biosciences
46. Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity
    Marwa S. Mahdy, Ahmed Farag Azmy, Tarek Dishisha, Wafaa R. Mohamed, Kawkab A. Ahmed, Ahmed M. Hassan, Sahar El Aidy, Ahmed Osama EL-Gendy · 2023 · BMC Microbiology
47. Age influences on the molecular presentation of tumours
    Constance H. Li, Syed Aleem Haider, Paul Christopher Boutros · 2022 · Nature Communications
48. Unveiling clinical applications of bacterial extracellular vesicles as natural nanomaterials in disease diagnosis and therapeutics
    Chun Liu, Negar Yazdani, Corey Stephen Moran, Carlos Salomon, Chaminda Jayampath Seneviratne, Sašo Ivanovski, Pingping Han · 2024 · Acta Biomaterialia
49. The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy
    José Antônio Fagundes Assumpção, Gabriel Pasquarelli-do-Nascimento, Mariana Saldanha Viegas, Martín Bonamino, Kelly Grace Magalhães · 2022 · Journal of Biomedical Science
50. Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection
    Eric R. Littmann, Jung‐Jin Lee, Joshua E. Denny, Zahidul Alam, Jeffrey R. Maslanka, Isma Zarin, Rina Matsuda, Rebecca A. Carter, Bože Sušac, Miriam Saffern et al. · 2021 · Nature Communications
51. Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer
    Mitra, Aparna, Grossman Biegert, Greyson Willis, Delgado, Andrea Y., Karpinets, Tatiana V., Solley, Travis N., Mezzari, Melissa P., Yoshida-Court, Kyoko, Petrosino, Joe F., Mikkelson, Megan D., Lin, Lilie et al. · 2020 · International Journal of Radiation Oncology*Biology*Physics
52. The honey bee gut microbiota: strategies for study and characterization
    S. Romero, A. Nastasa, Abigail Chapman, Waldan K. Kwong, Leonard J. Foster · 2019 · Insect Molecular Biology
53. Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters
    Shuyue Wang, Kun Xie, Tengfei Liu · 2021 · Frontiers in Immunology
54. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19
    David Schult, Sandra Reitmeier, Plamena Koyumdzhieva, Tobias Lahmer, Moritz A. Middelhoff, Johanna Erber, Jochen Schneider, Juliane Kager, Marina Frolova, Julia Horstmann et al. · 2022 · Gut Microbes
55. Moving immune therapy forward targeting tme
    Kayla F. Goliwas, Jessy S. Deshane, Craig A. Elmets, Mohammad Athar · 2020 · Physiological Reviews
56. The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
    Reza Bayat Mokhtari, Neda Ashayeri, Leili Baghaie, Manpreet Sambi, Kosar Satari, Narges Baluch, Dmitriy A. Bosykh, Myron R. Szewczuk, Sayan Chakraborty · 2023 · Cancers
57. Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers
    Karolina Kaźmierczak-Siedlecka, Giandomenico Roviello, Martina Catalano, Karol Połom · 2021 · Nutrients
58. Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
    Min-Woo Chung, Moon-Ju Kim, Eun Jeong Won, Yu Jeong Lee, Yong-Woon Yun, Sung Bum Cho, Young‐Eun Joo, Jun‐Eul Hwang, Woo Kyun Bae, Ik‐Joo Chung et al. · 2021 · World Journal of Gastroenterology
59. Diabetes medications and risk of HCC
    Plaz Torres, Maria Corina, Jaffe, Ariel, Perry, Rachel, Marabotto, Elisa, Strazzabosco, Mario, Giannini, Edoardo G. · 2022 · Hepatology
60. Surface Modifications for Improved Delivery and Function of Therapeutic Bacteria
    Ava M. Vargason, Shruti Santhosh, Aaron C. Anselmo · 2020 · Small
61. The Impact of Diet on Microbiota Evolution and Human Health. Is Diet an Adequate Tool for Microbiota Modulation?
    Laura Moles, David Otaegui · 2020 · Nutrients
62. Effect of Clostridium butyricum on Gastrointestinal Infections
    Tadashi Ariyoshi, Mao Hagihara, Motomichi Takahashi, Hiroshige Mikamo · 2022 · Biomedicines
63. The antitumour effects of caloric restriction are mediated by the gut microbiome
    Mao, Yu-Qin, Huang, Jia-Ting, Zhang, Shi-Long, Kong, Chao, Li, Zhan-Ming, Jing, Hui, Chen, Hui-Ling, Kong, Chao-Yue, Huang, Sheng-Hui, Cai, Pei-Ran et al. · 2023 · Nature Metabolism
64. Circulating exosomes and gut microbiome induced insulin resistance in mice exposed to intermittent hypoxia: Effects of physical activity
    Abdelnaby Khalyfa, Aaron C. Ericsson, Zhuanghong Qiao, Isaac Almendros, Ramón Farré, David Gozal · 2021 · EBioMedicine
65. Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study
    Yang Du, Yajuan Zhu, Yixin Zhou, Jing Ding, Jiyan Liu · 2022 · Molecular Biomedicine
66. Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop
    Dana H. Gabuzda, Beth D. Jamieson, Ronald G. Collman, Michael M. Lederman, Tricia H. Burdo, Steven G. Deeks, Dirk P. Dittmer, Howard S. Fox, Nicholas Funderburg, Savita G. Pahwa et al. · 2020 · Pathogens and Immunity
67. Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis
    Pan Chen, Xiangqi Tang · 2021 · Frontiers in Immunology
68. Intratumor microbiome in cancer progression: current developments, challenges and future trends
    Jinyan Liu, Yi Zhang · 2022 · Biomarker Research
69. The gut microbiome-immune axis as a target for nutrition-mediated modulation of food allergy
    Zhongliang Wang, Jinghua Zhong, Xuanyi Meng, Jinyan Gao, Hong Li, Jinlv Sun, Xin Li, Hongbing Chen · 2021 · Trends in Food Science & Technology
70. The Core Human Microbiome: Does It Exist and How Can We Find It? A Critical Review of the Concept
    Itai Sharon, Narciso Martín Quijada, Edoardo Pasolli, Marco Fabbrini, Francesco Vitali, Valeria Agamennone, Andreas Dötsch, Evelyne Selberherr, José Horacio Grau, Martin Meixner et al. · 2022 · Nutrients
71. The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis
    Farzaneh Fakharian, Behnoush Asgari, Ali Nabavi-Rad, Amir Sadeghi, Neda Soleimani, Abbas Yadegar, Mohammad Reza Zali · 2022 · Frontiers in Cellular and Infection Microbiology
72. The Crucial Role of Inflammation and the Immune System in Colorectal Cancer Carcinogenesis: A Comprehensive Perspective
    Antonio Manuel Burgos-Molina, Teresa Téllez Santana, Maximino Redondo, María José Bravo Romero · 2024 · International Journal of Molecular Sciences
73. Impacts of gut microbiota on gestational diabetes mellitus: a comprehensive review
    Lingling Huang, Chanisa Thonusin, Nipon Chattipakorn, Siriporn Chaisin Chattipakorn · 2021 · European Journal of Nutrition
74. The gut microbiome and efficacy of cancer immunotherapy
    Giandomenico Roviello, Luigi Francesco Iannone, Melissa Bersanelli, Enrico Mini, Martina Catalano · 2021 · Pharmacology & Therapeutics
75. Emerging Trends in Immunotherapy for Cancer
    Alok Mishra, Amjad Ali, Shubham Dutta, Shahid Banday, Sunil Kumar Malonia · 2022 · Diseases
76. Metabolic determinants of tumour initiation
    Julia S. Brunner, Lydia W.S. Finley · 2022 · Nature Reviews Endocrinology
77. Nanomaterials: small particles show huge possibilities for cancer immunotherapy
    Ziyin Chen, Ziqi Yue, Kaiqi Yang, Shenglong Li · 2022 · Journal of Nanobiotechnology
78. Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
    Yuanzhuo Gu, Zhengkui Zhang, Peter ten Dijke · 2023 · Cellular and Molecular Immunology
79. Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases
    Giovanni Martemucci, Giuseppe Fracchiolla, Marilena Muraglia, Roberta Tardugno, Roberta Savina Dibenedetto, Angela Gabriella D‘Alessandro · 2023 · Antioxidants
80. A dysbiotic microbiome promotes head and neck squamous cell carcinoma
    Daniel N. Frank, Yue Qiu, Yu Qing Cao, Shuguang Zhang, Ling Lu, Jennifer M. Kofonow, Charles E. Robertson, Yanqiu Liu, Haibo Wang, Cassandra L. Levens et al. · 2022 · Oncogene
81. Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives
    Ihsan Ullah, Le Yang, Fengting Yin, Ye Sun, Xinghua Li, Jing Li, Xijun Wang · 2022 · Cancers
82. Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process
    Massimo Saini, Barbara Maria Szczerba, Nicola Aceto · 2019 · Cancer Research
83. THE INTESTINAL MICROBIOME IN HUMAN HEALTH AND DISEASE.
    Herbert L. DuPont, Zhi‐Dong Jiang, Andrew W. Dupont, Netanya Sandler Utay · 2020 · PubMed
84. Cell-to-Cell Communication by Host-Released Extracellular Vesicles in the Gut: Implications in Health and Disease
    Natalia Díaz‐Garrido, Cecilia Cordero, Yenifer Olivo-Martínez, Josefa Badı́a, Laura Baldomà · 2021 · International Journal of Molecular Sciences
85. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy
    Yun Chen, Boyuan Liu, Wei Yuan, Dong‐Ming Kuang · 2021 · Pharmacological Research
86. The gut microbiota promotes the pathogenesis of schizophrenia via multiple pathways
    Xiuxia Yuan, Yulin Kang, Chuanjun Zhuo, Xu‐Feng Huang, Xueqin Song · 2019 · Biochemical and Biophysical Research Communications
87. Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer
    Dequan Liu, Xiangyu Che, Xiaoxi Wang, Chuanyu Ma, Guangzhen Wu · 2023 · Pharmaceuticals
88. Potential of Skin Microbiome, Pro- and/or Pre-Biotics to Affect Local Cutaneous Responses to UV Exposure
    Vijaykumar Patra, Irène Gallais Sérézal, Peter Wolf · 2020 · Nutrients
89. Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas
    Camilo Jiménez, Vivek Subbiah, Bettzy Stephen, Junsheng Ma, Denái R. Milton, Mingxuan Xu, Abdualrazzak Zarifa, Fechukwu Akhmedzhanov, Apostolia Maria Tsimberidou, Mouhammed Amir Habra et al. · 2020 · Cancers
90. Microbiota and Cancer: The Emerging Beneficial Role of Bifidobacteria in Cancer Immunotherapy
    Giulia Longhi, Douwe van Sinderen, Marco Ventura, Francesca Turroni · 2020 · Frontiers in Microbiology
91. Akkermansia supplementation reverses the tumor-promoting effect of the fecal microbiota transplantation in ovarian cancer
    Zizhuo Wang, Xu Qin, Dianxing Hu, Jia Ming Huang, Ensong Guo, Rourou Xiao, Wenting Li, Chaoyang Sun, Gang Chen · 2022 · Cell Reports
92. The Role of the Microbiome in the Etiopathogenesis of Colon Cancer
    Geniver El Tekle, Natalia Andreeva, Wendy S. Garrett · 2024 · Annual Review of Physiology
93. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy
    Yi, Ming, Jiao, Dechao, Qin, Shuang, Chu, Qian, Li, Anping, Wu, Kongming · 2019 · Integrative Cancer Therapies
94. Immunotherapy for hepatocellular carcinoma: Recent advances and future targets
    Su Jong Yu · 2023 · Pharmacology & Therapeutics
95. Keto microbiota: A powerful contributor to host disease recovery
    Amanda Cabrera-Mulero, Alberto Tinahones, Borja Bandera-Merchán, Isabel Moreno‐Indias, Manuel Macías‐González, Francisco José Tinahones · 2019 · Reviews in Endocrine and Metabolic Disorders
96. Microbiome harbored within tumors: a new chance to revisit our understanding of cancer pathogenesis and treatment
    Kunming Zhao, Ying Hu · 2020 · Signal Transduction and Targeted Therapy
97. The human microbiome and its link in prostate cancer risk and pathogenesis
    Paul Katongole, Obondo James Sande, Moses Lutaakome Joloba, Steven James Reynolds, Nixon Niyonzima · 2020 · Infectious Agents and Cancer
98. Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer
    Zhe Zhao, Kailun Fei, Hua Bai, Zhijie Wang, Jianchun Duan, Jie Wang · 2020 · Thoracic Cancer
99. Smectite promotes probiotic biofilm formation in the gut for cancer immunotherapy
    Congwei Han, Jinji Song, Junqing Hu, Huijie Fu, Yanxian Feng, Ruoyu Mu, Zhen Xing, Zhenzhen Wang, Lintao Wang, Junfeng Zhang et al. · 2021 · Cell Reports
100. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy
     Jianmin Wu, Shan Wang, Bo Jian Zheng, Xinyao Qiu, Hongyang Wang, Lei Chen · 2021 · Frontiers in Immunology